Skip to main
CTRE
CTRE logo

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 6 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 33%
Sell 17%
Strong Sell 0%

Bulls say

CareTrust REIT's planned $817 million merger with Care REIT reflects a positive outlook due to the immediate accretion it is expected to generate. Furthermore, the company's under-leveraged balance sheet provides significant potential for further deployment of capital, enhancing its financial flexibility. This strategic move into the UK market positions CareTrust REIT for growth, leveraging its established expertise in healthcare-related real estate investments.

Bears say

CareTrust REIT Inc. faces significant risks to its earnings growth due to potential tenant headwinds and disruptions that could hinder financial performance. The company's initial lease yield of 8.1% is considered low in comparison to the approximately 10% cash lease yields seen in other U.S. REIT peers, suggesting that CareTrust may not be maximizing its revenue potential. Additionally, tax leakage from the repatriation of profits to the U.S. could negatively impact investment yield by 50 to 100 basis points, further exacerbating the financial challenges facing the company.

CareTrust REIT (CTRE) has been analyzed by 6 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Hold based on their latest research and market trends.

According to 6 analysts, CareTrust REIT (CTRE) has a Hold consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.